CytoMed Therapeutics's three largest insider shareholders as of September 29, 2026 are Chee Kong Choo (Director, 630.32K shares), Chee Kong Choo (Director, 430.32K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Chee Kong Choo | Director, TenPercentOwner | 1,060,648 | 0 | 1,060,648 | 100.0% | 24 Jul, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 14 Jul, 2026 | Chee Kong Choo | Director, TenPercentOwner | Acquired P | 100,000 | $1.50 | $150.00K | 530,324 | Direct |
| 14 Jul, 2026 | Chee Kong Choo | Director, TenPercentOwner | Disposed P | 100,000 | $1.50 | $150.00K | 530,324 | Direct |
| 20 Jul, 2026 | Chee Kong Choo | Director, TenPercentOwner | Acquired P | 100,000 | $1.50 | $150.00K | 630,324 | Direct |
| 20 Jul, 2026 | Chee Kong Choo | Director, TenPercentOwner | Disposed P | 100,000 | $1.50 | $150.00K | 630,324 | Direct |
| 13 May, 2026 | Chee Kong Choo | Director, TenPercentOwner | Acquired P | 112,000 | $1.15 | $128.78K | 430,324 | Direct |